1887

Abstract

Amino acid substitutions of hepatitis B surface antigen (HBsAg) may affect the antigenicity and immunogenicity of HBsAg, leading to immune escape and diagnostic failure. The amino acid positions 122 and 160 are known as determinants for HBsAg subtypes / and /, respectively. The substitution K122I has been shown to strongly affect HBsAg antigenicity. In this study, we investigated the significance of naturally occurring amino acid substitutions K122I, T123N, A159G and K160N. Both T123N and K160N substitutions resulted in additional -glycosylated forms of HBsAg, while the other mutations produced more glycosylated HBsAg compared with the wild type (wt). Detection of HBsAg by ELISA and immunofluorescence staining indicated that variant HBsAg (vtHBsAg) with K122I was not recognized by HBsAg immunoassays, while vtHBsAg with T123N, A159G, K160N and A159G/K160N had reduced antigenicity. DNA immunization in BALB/c mice revealed that wtHBsAg and vtHBsAg with T123N and K160N are able to induce antibodies to HBsAg (anti-HBs), whereas K122I and A159G greatly impair the ability of HBsAg to trigger anti-HBs responses. The cellular immune response to the HBsAg aa 29–38 epitope was enhanced by the K160N substitution. Using replication competent clones of hepatitis B virus (HBV), T123N and A159G substitutions were shown to strongly reduce virion assembly. The amino acid substitution K160N appeared to compensate for the negative effect of A159G on virion production. These results reveal complex effects of amino acid substitutions on biochemical properties of HBsAg, on antigenicity and immunogenicity, and on the replication of HBV.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.012740-0
2010-02-01
2019-11-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/91/2/483.html?itemId=/content/journal/jgv/10.1099/vir.0.012740-0&mimeType=html&fmt=ahah

References

  1. Alexopoulou, A., Baltayiannis, G., Jammeh, S., Waters, J., Dourakis, S. P. & Karayiannis, P. ( 2004; ). Hepatitis B surface antigen variant with multiple mutations in the a determinant in an agammaglobulinemic patient. J Clin Microbiol 42, 2861–2865.[CrossRef]
    [Google Scholar]
  2. Carman, W. F. ( 1997; ). The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 4 (Suppl. 1), 11–20.[CrossRef]
    [Google Scholar]
  3. Carman, W. F., Zanetti, A. R., Karayiannis, P., Waters, J., Manzillo, G., Tanzi, E., Zuckerman, A. J. & Thomas, H. C. ( 1990; ). Vaccine-induced escape mutant of hepatitis B virus. Lancet 336, 325–329.[CrossRef]
    [Google Scholar]
  4. Carman, W. F., Owsianka, A., Wallace, L. A., Dow, B. C. & Mutimer, D. J. ( 1999; ). Antigenic characterization of pre- and post-liver transplant hepatitis B surface antigen sequences from patients treated with hepatitis B immune globulin. J Hepatol 31, 195–201.[CrossRef]
    [Google Scholar]
  5. Chen, J., Fang, F., Li, X., Chang, H. & Chen, Z. ( 2005; ). Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation. Vaccine 23, 4322–4328.[CrossRef]
    [Google Scholar]
  6. Cooreman, M. P., Leroux-Roels, G. & Paulij, W. P. ( 2001; ). Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci 8, 237–247.[CrossRef]
    [Google Scholar]
  7. Gavel, Y. & von Heijne, G. ( 1990; ). Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering. Protein Eng 3, 433–442.[CrossRef]
    [Google Scholar]
  8. Grethe, S., Monazahian, M., Böhme, I. & Thomssen, R. ( 1998; ). Characterization of unusual escape variants of hepatitis B virus isolated from hepatitis B surface antigen-negative subject. J Virol 72, 7692–7696.
    [Google Scholar]
  9. Gunther, S., Fischer, L., Pult, I., Sterneck, M. & Will, H. ( 1999; ). Naturally occurring variants of hepatitis B virus. Adv Virus Res 52, 25–137.
    [Google Scholar]
  10. Hou, J., Wang, Z., Cheng, J., Lin, Y., Lau, G. K., Sun, J., Zhou, F., Waters, J., Karayiannis, P. & Luo, K. ( 2001; ). Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology 34, 1027–1034.[CrossRef]
    [Google Scholar]
  11. Ireland, J. H., O'Donnell, B., Basuni, A. A., Kean, J. D., Wallace, L. A., Lau, G. K. K. & Carman, W. F. ( 2000; ). Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology 31, 1176–1182.[CrossRef]
    [Google Scholar]
  12. Kaplan, H. A., Welply, J. K. & Lennarz, W. J. ( 1987; ). Oligosaccharyl transferase: the central enzyme in the pathway of glycoprotein assembly. Biochim Biophys Acta 906, 161–173.[CrossRef]
    [Google Scholar]
  13. Karayiannis, P., Alexopoulou, A., Hadziyannis, S., Thursz, M., Watts, R., Seito, S. & Thomas, H. C. ( 1995; ). Fulminant hepatitis associated with hepatitis B virus e antigen-negative infection: importance of host factors. Hepatology 22, 1628–1634.
    [Google Scholar]
  14. Kay, A. & Zoulim, F. ( 2007; ). Hepatitis B virus genetic variability and evolution. Virus Res 127, 164–176.[CrossRef]
    [Google Scholar]
  15. Lei, Y. C., Hao, Y. H., Zhang, Z. M., Tian, Y. J., Wang, B. J., Yang, Y., Zhao, X. P., Lu, M. J., Gong, F. L. & Yang, D. L. ( 2006; ). Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo. World J Gastroenterol 12, 4492–4497.
    [Google Scholar]
  16. Lu, M. & Lorentz, T. ( 2003; ). De novo infection in a renal transplant recipient caused by novel mutants of hepatitis B virus despite the presence of protective anti-hepatitis B surface antibody. J Infect Dis 187, 1323–1326.[CrossRef]
    [Google Scholar]
  17. Marshall, R. D. ( 1974; ). The nature and metabolism of the carbohydrate-peptide linkages of glycoproteins. Biochem Soc Symp 40, 17–26.
    [Google Scholar]
  18. Mellquist, J. L., Kasturi, L., Spitalnik, S. L. & Shakin-Eshleman, S. H. ( 1998; ). The amino acid following an asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency. Biochemistry 37, 6833–6837.[CrossRef]
    [Google Scholar]
  19. Meng, Z., Xu, Y., Wu, J., Tian, Y., Kemper, T., Bleekmann, B., Roggendorf, M., Yang, D. & Lu, M. ( 2008; ). Inhibition of hepatitis B virus gene expression and replication by endoribonuclease-prepared siRNA. J Virol Methods 150, 27–33.[CrossRef]
    [Google Scholar]
  20. Okamoto, H., Imai, M., Tsuda, F., Tanaka, T., Miyakawa, Y. & Mayumi, M. ( 1987; ). Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J Virol 61, 3030–3034.
    [Google Scholar]
  21. Parekh, S., Zoulim, F., Ahn, S. H., Tsai, A., Li, J., Kawai, S., Khan, N., Trepo, C., Wands, J. & Tong, S. ( 2003; ). Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J Virol 77, 6601–6612.[CrossRef]
    [Google Scholar]
  22. Peterson, D. L. ( 1981; ). Isolation and characterization of the major protein and glycoprotein of hepatitis B surface antigen. J Biol Chem 256, 6975–6983.
    [Google Scholar]
  23. Schmitt, S., Glebe, D., Alving, K., Tolle, T. K., Linder, M., Geyer, H., Linder, D., Peter-Katalinic, J., Gerlich, W. H. & Geyer, R. ( 1999; ). Analysis of the pre-S2 N- and O-linked glycans of the M surface protein from human hepatitis B virus. J Biol Chem 274, 11945–11957.[CrossRef]
    [Google Scholar]
  24. Seddigh-Tonekaboni, S., Waters, J. A., Jeffers, S., Gehrke, R., Ofenloch, B., Horsch, A., Hess, G., Thomas, H. C. & Karayiannis, P. ( 2000; ). Effect of variation in the common “a” determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 60, 113–121.[CrossRef]
    [Google Scholar]
  25. Shi, X. & Elliott, R. M. ( 2004; ). Analysis of N-linked glycosylation of hantaan virus glycoproteins and the role of oligosaccharide side chains in protein folding and intracellular trafficking. J Virol 78, 5414–5422.[CrossRef]
    [Google Scholar]
  26. Tai, P. C., Suk, F. M., Gerlich, W. H., Neurath, A. R. & Shih, C. ( 2002; ). Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants. Virology 292, 44–58.[CrossRef]
    [Google Scholar]
  27. Tian, Y., Xu, Y., Zhang, Z., Meng, Z., Qin, L., Lu, M. & Yang, D. ( 2007; ). The amino acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen. J Clin Microbiol 45, 2971–2978.[CrossRef]
    [Google Scholar]
  28. Wang, Q., Wang, Y., Liang, C., Song, J. & Chen, X. ( 2008; ). Identification of a hydrophobic domain of HA2 essential to morphogenesis of Helicoverpa armigera nucleopolyhedrovirus. J Virol 82, 4072–4081.[CrossRef]
    [Google Scholar]
  29. Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M. & other authors ( 2003; ). Antibody neutralization and escape by HIV-1. Nature 422, 307–312.[CrossRef]
    [Google Scholar]
  30. Weinberger, K. M., Bauer, T., Bohm, S. & Jilg, W. ( 2000; ). High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 81, 1165–1174.
    [Google Scholar]
  31. Widera, G., Austin, M., Rabussay, D., Goldbeck, C., Barnett, S. W., Chen, M., Leung, L., Otten, G. R., Thudium, K. & other authors ( 2000; ). Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 164, 4635–4640.[CrossRef]
    [Google Scholar]
  32. Zhang, M., Gaschen, B., Blay, W., Foley, B., Haigwood, N., Kuiken, C. & Korber, B. ( 2004; ). Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 14, 1229–1246.[CrossRef]
    [Google Scholar]
  33. Zheng, X., Weinberger, K. M., Gehrke, R., Isogawa, M., Hilken, G., Kemper, T., Xu, Y., Yang, D., Jilg, W. & other authors ( 2004; ). Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity. Virology 329, 454–464.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.012740-0
Loading
/content/journal/jgv/10.1099/vir.0.012740-0
Loading

Data & Media loading...

Supplements

vol. , part 2, pp. 483 - 492

Primers used in this paper

The relative proportions of virions and naked cores for the replication competent clones in the present study [Single PDF file](43 KB)



PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error